Singapore, Nov. 17 -- 10x Genomics, Inc. has announced two new research collaborations focused on identifying blood-based biomarkers of disease activity and treatment response for autoimmune disease. The first collaboration is with Charite - Universitatsmedizin Berlin, one of Europe's largest university hospitals, and the German Rheumatology Research Center Berlin (DRFZ). The second is with the Genomic Medicine Institute at Seoul National University (SNU), one of South Korea's leading research universities.

Earlier this year, 10x outlined its clinical strategy for realising the potential of single cell and spatial technologies in diagnostics, with a focus on oncology and autoimmune disease. These two new collaborations expand 10x's autoi...